NCT04718025: Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
- State
- State not given
- Phase
- Phase 3
- People
- 4,500 planned
- Started
- 7 Feb 2022
- Primary completion
- 30 Jun 2024
- Arms
- Low-dose ticagrelor with aspirin (LDTA), Low-dose ticagrelor with placebo (LDTP)
- Results
- None posted
- Papers
- doi:10.5603/cj.a2021.0056
- 22 Jan 2021: Trial registered
- 7 Feb 2022: Trial started